A Phase 1 study of RN-1101
- Conditions
- Solid tumor
- Registration Number
- JPRN-jRCT2031220477
- Lead Sponsor
- Yoshimatsu Kentaro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 88
1. Cytologically- or histologically-confirmed diagnosis of a locally advanced or metastatic solid tumor
2. Refractory to or intolerable with standard treatment, or for which no standard treatment is available
3. Age 18 years or older
4. Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 1
5. Willing and able to provide informed consent
6. Mesureable disease per RECIST version 1.1
1. Has multiple primary malignancies within 2 years
2. Has clinically active brain metastases
3. Has a history of Interstitial pneumonia
4. Known HIV infection
5. Known ative hapatitis B or C infection
6. Is pregnant as confirmed or possible, or a lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method